STOCK TITAN

Fortress Biotech (FBIO) 424B Filings

FBIO NASDAQ

Here are the 424B prospectus supplements from Fortress Biotech, Inc. (FBIO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow FBIO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FBIO filings page.

Rhea-AI Summary

Fortress Biotech, Inc. is registering up to 600,000 shares of its common stock for resale by Oaktree Fund Administration, LLC and affiliated selling stockholders. These shares are issuable upon exercise of warrants granted under a credit agreement amendment.

The selling stockholders may sell the shares over time on Nasdaq or in private transactions, using various methods described in the plan of distribution. Fortress will pay the registration costs but will not receive any proceeds from the resale of these shares. Its common stock trades on the Nasdaq Capital Market under the symbol FBIO, and 31,037,937 shares were outstanding as of December 11, 2025.